全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Water Mediated Synthesis of N′-Arylmethylene-4,5,6,7-tetrahydro-2H-indazole-3-carbohydrazide Library

DOI: 10.1155/2014/567053

Full-Text   Cite this paper   Add to My Lib

Abstract:

A novel two-step synthesis of 4,5,6,7-tetrahydro-2H-indazole-3-carbohydrazide has been developed. The library of N′-arylmethylene-4,5,6,7-tetrahydro-2H-indazole-3-carbohydrazide was generated by coupling of hydrazide to various aromatic and heterocyclic aldehydes in water media at ambient temperature with great flexibility regarding reaction time and yield. 1. Introduction Derivatives of indazole and other pyrazole-containing condensed systems are attracting attention because of their biological activity and the possibilities of further conversions. Anti-inflammatory, analgesic, antipyretic, and antirheumatic activity has been reported for pyrazole derivatives [1–3]. One of these derivatives, 2-(1-phenyl-pyrazole-4-yl)propionic acid I (Figure 1), has been shown to be clinically active in the treatment of rheumatic disorders. In addition, it has been reported that pyrazole corticoids III, IV (Figure 1) are more active than parent corticoids. One of these derivatives, 17α,21-dihydroxy-20-oxopregn-4-eno[3,2-c]-2′-(4-fluorophenyl) pyrazole II (Figure 1) [4], has been used clinically as a topical anti-inflammatory agent. However, literature reveals that 4,5,6,7-tetrahydro-2H-indazole derivatives exhibit dopaminergic [5], anti-inflammatory [6], herbicidal [7], and antitumor [8] activity and cannabinoid modulators [9], as HMG-COA reductase inhibitors [10]. Hydrazide analogues also possess other biological activities like anticonvulsant [11], antidepressant [12], anti-inflammatory [13], antimalarial [14], antimycobacterial [15], anticancer [16], and antimicrobial [17–21] activities. Figure 1 Our Continuous efforts for the synthesis of various novel heterocycles for biological interest using various catalyst and green approaches [22–26] and the remarkable pharmaceutical importance of fused hydrazide and pyrazole derivatives, prompted us to design and synthesize a scaffold 4,5,6,7-tetrahydro-2H-indazole-3-carbohydrazide using water as a green solvent. 2. Materials and Methods Melting points were determined on electrothermal apparatus using open capillaries and are uncorrected. Thin-layer chromatography was accomplished on 0.2?mm precoated plates of silica gel G60 F254 (Merck). Visualization was made with UV light (254 and 365?nm) or with an iodine vapor. IR spectra were recorded on a FTIR-8400 spectrophotometer using DRS prob. 1H NMR spectra were recorded on a Bruker AVANCE II (400?MHz) spectrometer in DMSO. Chemical shifts are expressed in δ?ppm downfield from TMS as an internal standard. Mass spectra were determined using direct inlet probe on a GCMS-QP 2010

References

[1]  “Orally administrable opioid formulations having extended duration of effect,” French Patent 2133 503, 1972.
[2]  “Heterocyclic substituted pyrazole-4-acetic acids,” German Offen. 2141124, 1972.
[3]  J. H. Fried, H. Mrozik, G. E. Arth et al., “16-Methylated steroids. IV. 6,16α-dimethyl-6-hydrocortisone and related compounds,” Journal of the American Chemical Society, vol. 85, no. 2, pp. 236–238, 1963.
[4]  J. Hannah, K. Kelly, A. A. Patchett, S. L. Steelman, and E. R. Morgan, “Substituted pyrazolo corticoids as topical antiinflammatory agents,” Journal of Medicinal Chemistry, vol. 18, no. 2, pp. 168–172, 1975.
[5]  L. A. McQuaid, J. E. Latz, J. A. Clemens, R. W. Fuller, D. T. Wong, and N. R. Mason, “Substituted 5-amino-4,5,6,7-tetrahydroindazoles as partial ergoline structures with dopaminergic activity,” Journal of Medicinal Chemistry, vol. 32, no. 10, pp. 2388–2396, 1989.
[6]  M. Suzanne, “Substituted Pyrazolyl Compounds For The Treatment Of Inflammation,” US Patent no. 7211597 B2, 2007.
[7]  A. D. Wolf, “Tetrahydroindazole herbicides,” US Patent no. 4124373, 1978.
[8]  P. Pevarello, “4,5,6,7-tetrahydroindazole derivatives as antitumor agents,” US 6716856 B1, 2004.
[9]  B. Lagu, “Tetrahydro-indazole cannabinoid modulators,” WO 095353 A1, 2005.
[10]  P. J. Conolly, “Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors,” US 5134155, 1992.
[11]  J. V. Ragavendran, D. Sriram, S. K. Patel et al., “Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore,” European Journal of Medicinal Chemistry, vol. 42, no. 2, pp. 146–151, 2007.
[12]  N. Ergenc and N. S. Gunay, “Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives,” European Journal of Medicinal Chemistry, vol. 33, no. 2, pp. 143–148, 1998.
[13]  A. R. Todeschini, A. L. P. de Miranda, K. C. M. da Silva, S. C. Parrini, and E. J. Barreiro, “Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives,” European Journal of Medicinal Chemistry, vol. 33, no. 3, pp. 189–199, 1998.
[14]  S. Gemma, G. Kukreja, C. Fattorusso et al., “Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 20, pp. 5384–5388, 2006.
[15]  A. Bijev, “New heterocyclic hydrazones in the search for antitubercular agents: synthesis and in vitro evaluations,” Letters in Drug Design and Discovery, vol. 3, no. 7, pp. 506–512, 2006.
[16]  B. N. Swamy, T. K. Suma, G. V. Rao, and G. C. Reddy, “Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis,” European Journal of Medicinal Chemistry, vol. 42, no. 3, pp. 420–424, 2007.
[17]  A. Masunari and L. C. Tavares, “A new class of nifuroxazide analogues: synthesis of 5-nitrothiophene derivatives with antimicrobial activity against multidrug-resistant Staphylococcus aureus,” Bioorganic and Medicinal Chemistry, vol. 15, no. 12, pp. 4229–4236, 2007.
[18]  C. Loncle, J. M. Brunel, N. Vidal, M. Dherbomez, and Y. Letourneux, “Synthesis and antifungal activity of cholesterol-hydrazone derivatives,” European Journal of Medicinal Chemistry, vol. 39, no. 12, pp. 1067–1071, 2004.
[19]  S. G. Kü?ükgüzel, A. Mazi, F. Sahin, S. ?ztürk, and J. Stables, “Synthesis and biological activities of diflunisal hydrazide-hydrazones,” European Journal of Medicinal Chemistry, vol. 38, no. 11-12, pp. 1005–1013, 2003.
[20]  P. Vicini, F. Zani, P. Cozzini, and I. Doytchinova, “Hydrazones of 1,2-benzisothiazole hydrazides: Synthesis, antimicrobial activity and QSAR investigations,” European Journal of Medicinal Chemistry, vol. 37, no. 7, pp. 553–564, 2002.
[21]  H. R. Snyder, L. A. Brooks, and S. H. Shapiro, “Pimelic acid,” Organic Synthesis, vol. 11, p. 42, 1931.
[22]  M. M. Savant, A. M. Pansuriya, C. V. Bhuva et al., “Water mediated construction of trisubstituted pyrazoles/isoxazoles library using ketene dithioacetals,” Journal of Combinatorial Chemistry, vol. 12, no. 1, pp. 176–180, 2010.
[23]  M. M. Savant, N. S. Gowda, A. M. Pansuriya et al., “A concise synthetic strategy to functionalized chromenones via [5+1] heteroannulation and facile C-N/C-S/C-O bond formation with various nucleophiles,” Tetrahedron Letters, vol. 52, no. 2, pp. 254–257, 2011.
[24]  M. M. Savant, A. M. Pansuriya, C. V. Bhuva, N. P. Kapuriya, and Y. T. Naliapara, “Etidronic acid: a new and efficient catalyst for the synthesis of novel 5-nitro-3,4-dihydropyrimidin-2(1H)-ones,” Catalysis Letters, vol. 132, no. 1-2, pp. 281–284, 2009.
[25]  M. M. Savant, C. V. Bhuva, A. M. Pansuriya et al., “Synthesis of some novel trifluoromethylated tetrahydropyrimidines using etidronic acid and evaluation for antimicrobial activity,” Der Pharmacia Lettre, vol. 1, no. 2, pp. 277–285, 2009.
[26]  A. M. Pansuriya, M. M. Savant, C. V. Bhuva, J. Singh, and Y. T. Naliapara, “One-pot synthesis of 5-carboxanilide-dihydropyrimidinones using etidronic Acid,” Arkivoc, vol. 2009, no. 7, pp. 79–85, 2009.

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133